Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma

Figure 3

Kaplan–Meier analysis of PFS in subgroups of CTC-positive HCC patients. (a) Tumor size <3 cm. (b) Without PVT. (c) Without MVI. (d) Tumor number <3. (e) Tumor stage (I-II). (f) Edmonson stage (I-II). (g) With cirrhosis. (h) HBsAg (+). PVT: portal vein thrombosis; MVI: microvascular invasions; HBsAg: hepatitis B surface antigen.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)